1 The intention-to-treat principle was used in the analysis if
2 The intention-to-treat principle was used to extend the initi
3 The primary endpoint was disease-free survival, analysed
by the intention-to-treat principle using a stratified log-rank
4 It also focuses on specific issues
concerning the intention-to-treat principle and longitudinal data analys
5 Primary analyses
followed the intention to treat principle.
6 Analyses
followed the intention-to-treat principle, accounted for clustering by
7 Data analyses
followed the intention-to-treat principle.
8 All analyses
followed the intention-to-treat principle.
9 The analysis
followed the intention-to-treat principle.
10 Analysis
followed the intention-to-treat principle.
11 All analysis
followed the intention-to-treat principle.
12 Assessment of outcomes was blinded and
followed the intention-to-treat principle, including all randomised pa
13 Limitation:
The intention-to-treat principle was maintained for MMD burde
14 The primary analysis was performed on the basis
of the intention-to-treat principle.
15 The primary analysis was based
on the intention-to-treat principle and compared mortality rates
16 All analyses were based
on the intention-to-treat principle and the study population con
17 The primary analysis was based
on the intention-to-treat principle without imputation and all s
18 Analyses were performed based
on the intention-to-treat principle.
19 Analysis was based
on the intention-to-treat principle.
20 The primary analysis was based
on the intention-to-treat principle.
21 collected and combined with a fixed-effects model based
on the intention-to-treat principle.
22 The primary end points were analyzed according
to the intention-to-treat principle and were tested with the use
23 t a university hospital dermatology department according
to the intention-to-treat principle with last observation carrie
24 Comparisons were made according
to the intention-to-treat principle, and CIs were calculated usi
25 Analyses were performed according
to the intention-to-treat principle, with the use of mixed-effec
26 Primary analyses were performed according
to the intention-to-treat principle.
27 The analysis was performed according
to the intention-to-treat principle.
28 Complete 6-year data were analyzed according
to the intention-to-treat principle.
29 Analysis was performed according
to the intention-to-treat principle.
30 ed up for 12 months and the data were analyzed according
to the intention-to-treat principle.
31 low-up 30 days after surgery and were analyzed according
to the intention-to-treat principle.
32 All effectiveness analyses were done according
to the intention-to-treat principle.
33 Data were analyzed according
to the intention-to-treat principle.
34 30 days after surgery, and data were analyzed according
to the intention-to-treat principle.
35 of the hospital stay, with analyses conducted according
to the intention-to-treat principle.
36 Analysis was done according
to the intention-to-treat principle.
37 re analyzed for all randomly assigned patients according
to the intention-to-treat principle.
38 fects were estimated using linear mixed models according
to the intention-to-treat principle.
39 Analyses were done according
to the intention-to-treat principle.
40 Analysis was performed according
to the intention-to-treat principle.
41 Outcomes were analyzed according
to the intention-to-treat principle.
42 The analysis was performed according
to the intention-to-treat principle.
43 Analyses were performed according
to the intention-to-treat principle.Between October 2014 and Mar
44 Response rates were compared
under the intention-to-treat principle, including all randomized pa
45 The analyses were done in accordance
with the intention-to-treat principle.
46 We analysed clinical outcomes
with the intention-to-treat principle and analysis of safety outco